WO2014064714A3 - Process for preparation of lurasidone hydrochloride - Google Patents

Process for preparation of lurasidone hydrochloride Download PDF

Info

Publication number
WO2014064714A3
WO2014064714A3 PCT/IN2013/000638 IN2013000638W WO2014064714A3 WO 2014064714 A3 WO2014064714 A3 WO 2014064714A3 IN 2013000638 W IN2013000638 W IN 2013000638W WO 2014064714 A3 WO2014064714 A3 WO 2014064714A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
lurasidone hydrochloride
lurasidone
hydrochloride
provides
Prior art date
Application number
PCT/IN2013/000638
Other languages
French (fr)
Other versions
WO2014064714A2 (en
Inventor
Sunil Kumar Singh
Sachin Srivastava
Dinesh Bansilal Deore
Shekhar Bhaskar Bhirud
Original Assignee
Glenmark Pharmaceuticals Limited; Glenmark Generics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Limited; Glenmark Generics Limited filed Critical Glenmark Pharmaceuticals Limited; Glenmark Generics Limited
Publication of WO2014064714A2 publication Critical patent/WO2014064714A2/en
Publication of WO2014064714A3 publication Critical patent/WO2014064714A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a process for the preparation of lurasidone hydrochloride.
PCT/IN2013/000638 2012-10-22 2013-10-18 Process for preparation of lurasidone hydrochloride WO2014064714A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN3079/MUM/2012 2012-10-22
IN3079MU2012 2012-10-22
US201261734652P 2012-12-07 2012-12-07
US61/734,652 2012-12-07

Publications (2)

Publication Number Publication Date
WO2014064714A2 WO2014064714A2 (en) 2014-05-01
WO2014064714A3 true WO2014064714A3 (en) 2014-06-05

Family

ID=50545426

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2013/000638 WO2014064714A2 (en) 2012-10-22 2013-10-18 Process for preparation of lurasidone hydrochloride

Country Status (1)

Country Link
WO (1) WO2014064714A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3242876A4 (en) * 2015-01-08 2019-01-02 Piramal Enterprises Limited An improved process for the preparation of lurasidone and its intermediate
JP2024511693A (en) * 2021-03-31 2024-03-15 四川科▲倫▼▲薬▼物研究院有限公司 Injectable lurasidone suspension and method for producing the same
CN115073444A (en) * 2022-08-05 2022-09-20 山东科源制药股份有限公司 Method for refining and removing lurasidone hydrochloride epoxy impurities

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532372A (en) * 1990-07-06 1996-07-02 Sumitomo Pharmaceuticals Company, Ltd. Imide derivatives, and their production and use
WO2005009999A1 (en) * 2003-07-29 2005-02-03 Dainippon Sumitomo Pharma Co., Ltd. Process for producing imide compound
WO2012107890A2 (en) * 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Crystalline forms of lurasidone hydrochloride
CN102731512A (en) * 2011-04-12 2012-10-17 天津药物研究院 Preparation method of lurasidone intermediate and lurasidone
CN102911169A (en) * 2011-08-02 2013-02-06 上海医药工业研究院 Method for preparing lurasidone

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532372A (en) * 1990-07-06 1996-07-02 Sumitomo Pharmaceuticals Company, Ltd. Imide derivatives, and their production and use
WO2005009999A1 (en) * 2003-07-29 2005-02-03 Dainippon Sumitomo Pharma Co., Ltd. Process for producing imide compound
WO2012107890A2 (en) * 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Crystalline forms of lurasidone hydrochloride
CN102731512A (en) * 2011-04-12 2012-10-17 天津药物研究院 Preparation method of lurasidone intermediate and lurasidone
CN102911169A (en) * 2011-08-02 2013-02-06 上海医药工业研究院 Method for preparing lurasidone

Also Published As

Publication number Publication date
WO2014064714A2 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
EP3256454A4 (en) Integrated methods for chemical synthesis
EP2677888B8 (en) Garment for the neuro-musculo-skeletal assistance
EP3378850B8 (en) Processes for the preparation of (s)-1-(3-ethoxy-4methoxyphenyl)-2-methanesulfonylethylamine
PL2791093T3 (en) Process for the preparation of 2, 3, 3, 3 tetrafluoropropene
WO2014041560A3 (en) Process for the preparation of teneligliptin
EP3504196A4 (en) Processes for preparing olaparib
EP2888105A4 (en) Material for carton, blank, or substrate
EP3057935A4 (en) Process for forming primary, secondary or tertiary amine via direct amination reaction
IL236450A (en) Process for the preparation of 5-fluoro-1h-pyrazoles
PL399419A1 (en) Process for the preparation of 4-methoxydihydrochalcone
PL399418A1 (en) Process for the preparation of 4-methoxydihydrochalcone
PL2563478T3 (en) Process for the preparation of a pharmaceutically effective extract from arthrospira spec.
EP3016935A4 (en) Process for the preparation of intermediate of dolutegravir
WO2014207758A3 (en) Novel polymorph of regadenoson
EP2885302A4 (en) Process for the preparation of dipeptidylpeptidase inhibitors
EP3207041A4 (en) An improved process for the preparation of lurasidone hydrochloride
EP3068770A4 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
HUE040536T2 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
WO2014064714A3 (en) Process for preparation of lurasidone hydrochloride
SG11201408703YA (en) Integrated process for the preparation of olefins
PL2747580T3 (en) Process for the manufacture of an infusible beverage ingredient
EP2882291A4 (en) An improved process for the preparation of memantine hydrochloride
EP3221320A4 (en) A process for the preparation of ibrutinib
EP3089959A4 (en) Process for making ethanolamines
WO2015022707A3 (en) Process for the synthesis of trifluoromethanesulfonic acid

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13848743

Country of ref document: EP

Kind code of ref document: A2